Cargando…
Mitochondria-Targeted, Nanoparticle-Based Drug-Delivery Systems: Therapeutics for Mitochondrial Disorders
Apart from ATP generation, mitochondria are involved in a wide range of functions, making them one of the most prominent organelles of the human cell. Mitochondrial dysfunction is involved in the pathophysiology of several diseases, such as cancer, neurodegenerative diseases, cardiovascular diseases...
Autores principales: | Buchke, Sakshi, Sharma, Muskan, Bora, Anusuiya, Relekar, Maitrali, Bhanu, Piyush, Kumar, Jitendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144057/ https://www.ncbi.nlm.nih.gov/pubmed/35629325 http://dx.doi.org/10.3390/life12050657 |
Ejemplares similares
-
Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin
por: Bhanu, Piyush, et al.
Publicado: (2020) -
Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis
por: Bhanu1, Piyush, et al.
Publicado: (2023) -
Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery Approaches
por: Khan, Tanzeel, et al.
Publicado: (2022) -
Recent Advancements in Mitochondria-Targeted Nanoparticle Drug Delivery for Cancer Therapy
por: Xu, Jiangsheng, et al.
Publicado: (2022) -
Mitochondria-Targeted Drug Delivery
por: Kopecka, Joanna
Publicado: (2022)